TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    Investing

    Is Valeant Pharmaceuticals Intl Inc. Canada’s Cheapest Stock?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) trades at just two times trailing free cash flow. But that doesn't tell the whole…

    Read more »

    caution
    Investing

    Why You Shouldn’t Own Valeant Pharmaceuticals Intl Inc.

    The latest news from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is proof that Bill Ackman was wise to get out.

    Read more »

    The Motley Fool
    Investing

    Investors: Forget Valeant Pharmaceuticals Intl Inc.: Check Out CRH Medical Corp. Instead

    Invest in CRH Medical Corp. (TSX:CRH) for exposure to a growing and profitable healthcare company.

    Read more »

    The Motley Fool
    Investing

    What We Can Learn From Bill Ackman Walking Away From Valeant Pharmaceuticals Intl Inc.

    Investors can learn a lot from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Has Valeant Pharmaceuticals Intl Inc. Hit the Bottom?

    With long-time investors dropping Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), questions remain: has the stock truly hit the bottom, and can…

    Read more »

    The Motley Fool
    Investing

    Bill Ackman Throws in the Towel on Valeant Pharmaceuticals Intl Inc.

    Bill Ackman finally dumped his entire stake in Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX). If you haven't already, you should probably…

    Read more »

    The Motley Fool
    Investing

    Billionaire Bill Ackman Just Sold Valeant Pharmaceuticals Intl Inc.: Should You Sell Too?

    Bill Ackman just sold 27.2 million Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares. Should you sell too, or does this move…

    Read more »

    caution
    Investing

    3 Red Flags That Signal it’s Time to Sell: Learning From the Past

    The lessons investors can learn from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), Sierra Wireless, Inc. (TSX:SW)(NASDAQ:SWIR), and Ballard Power Systems Inc.…

    Read more »

    The Motley Fool
    Investing

    Why Shares of Valeant Pharmaceuticals Intl Inc. Plunged Yet Again

    Debt refinancing reminds investors of continuing trouble at Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is the Reward Worth the Risk?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has a plan to get out of debt, but it's going to take pristine execution.

    Read more »

    The Motley Fool
    Investing

    Another Cut for Valeant Pharmaceuticals Intl Inc.

    With another disappointing earnings release, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be yet another case of death by a thousand…

    Read more »

    The Motley Fool
    Investing

    Stay Away From Valeant Pharmaceuticals Intl Inc.

    Investors: stop dreaming of a comeback. Just stay away from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »